Stressin1-A, a Potent Corticotropin Releasing Factor Receptor 1 (CRF1)-Selective Peptide Agonist
- 3 March 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (7) , 1668-1674
- https://doi.org/10.1021/jm0613875
Abstract
The potencies and selectivity of peptide CRF antagonists is increased through structural constraints, suggesting that the resulting ligands assume distinct conformations when interacting with CRF1 and CRF2 receptors. To develop selective CRF receptor agonists, we have scanned the sequence -Gln-Ala-His-Ser-Asn-Arg- (residues 30−35 of [DPhe12,Nle21,38]Ac-hCRF4-41) with an i−(i+3) bridge consisting of the Glui-Xaa-Xbb-Lysi+3 scaffold, where residues i = 30, 31, and 32. When i = 31, stressin1-A, a potent CRF1 receptor-selective agonist was generated. In vitro, stressin1-A was equipotent to h/rCRF to release ACTH. Astressin1-A showed a low nanomolar affinity for CRF1 receptor (Ki = 1.7 nM) and greater than 100-fold selectivity versus CRF2 receptor (Ki = 222 nM). Stressin1-A released slightly less ACTH than oCRF in adult adrenal-intact male rats, with increased duration of action. Stressin1-A, injected intraperitoneally in rats, induced fecal pellet output (a CRF1 receptor-mediated response) and did not influence gastric emptying and blood pressure (CRF2 receptor-mediated responses).Keywords
This publication has 32 references indexed in Scilit:
- CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in ratsGut, 2006
- CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilatorsBritish Journal of Pharmacology, 2004
- Role of peripheral CRF signalling pathways in stress‐related alterations of gut motility and mucosal functionNeurogastroenterology & Motility, 2004
- CRF1receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndromeBritish Journal of Pharmacology, 2004
- CRF and CRF Receptors: Role in Stress Responsivity and Other BehaviorsAnnual Review of Pharmacology and Toxicology, 2004
- International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their LigandsPharmacological Reviews, 2003
- Differential Actions of Peripheral Corticotropin-Releasing Factor (CRF), Urocortin II, and Urocortin III on Gastric Emptying and Colonic Transit in Mice: Role of CRF Receptor Subtypes 1 and 2The Journal of Pharmacology and Experimental Therapeutics, 2002
- Constrained Corticotropin Releasing Factor Antagonists (Astressin Analogues) with Long Duration of Action in the RatJournal of Medicinal Chemistry, 1999
- Conformationally Restricted Competitive Antagonists of Human/Rat Corticotropin-Releasing FactorJournal of Medicinal Chemistry, 1994
- Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the RatScience, 1984